SBC Medical Group Holdings Incorporated
SBC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $43,353 | $43,359 | $47,329 | $44,421 |
| % Growth | -0% | -8.4% | 6.5% | – |
| Cost of Goods Sold | $13,452 | $13,348 | $9,596 | $10,548 |
| Gross Profit | $29,901 | $30,011 | $37,733 | $33,872 |
| % Margin | 69% | 69.2% | 79.7% | 76.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $13,419 | $12,142 | $12,674 |
| SG&A Expenses | $14,020 | $14,393 | $12,824 | $13,901 |
| Sales & Mktg Exp. | $0 | $974 | $682 | $1,226 |
| Other Operating Expenses | $0 | $1,064 | $707 | $15,254 |
| Operating Expenses | $14,020 | $15,456 | $13,531 | $29,155 |
| Operating Income | $15,881 | $14,554 | $24,202 | $4,718 |
| % Margin | 36.6% | 33.6% | 51.1% | 10.6% |
| Other Income/Exp. Net | $2,626 | -$1,014 | $7,249 | $1,342 |
| Pre-Tax Income | $18,507 | $13,540 | $31,451 | $6,059 |
| Tax Expense | $5,674 | $11,101 | $9,959 | -$489 |
| Net Income | $12,825 | $2,458 | $21,502 | $6,539 |
| % Margin | 29.6% | 5.7% | 45.4% | 14.7% |
| EPS | 0.125 | 0.024 | 0.208 | 0.064 |
| % Growth | 424.8% | -88.6% | 227.4% | – |
| EPS Diluted | 0.125 | 0.024 | 0.208 | 0.064 |
| Weighted Avg Shares Out | 102,643 | 103,507 | 103,277 | 102,751 |
| Weighted Avg Shares Out Dil | 102,643 | 103,507 | 103,277 | 102,751 |
| Supplemental Information | – | – | – | – |
| Interest Income | $120 | $23 | $55 | $0 |
| Interest Expense | $49 | $50 | $6 | $12 |
| Depreciation & Amortization | $715 | $636 | $628 | $932 |
| EBITDA | $19,270 | $14,226 | $32,086 | $7,003 |
| % Margin | 44.4% | 32.8% | 67.8% | 15.8% |